Next Article in Journal
Neonatal Piglet Temperature Changes: Effect of Intraperitoneal Warm Saline Injection
Previous Article in Journal
Effects of Dietary Supplementation with Glycerol Monolaurate (GML) or the Combination of GML and Tributyrin on Growth Performance and Rumen Microbiome of Weaned Lambs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

NDM-5-Producing Escherichia coli Co-Harboring mcr-1 Gene in Companion Animals in China

1
National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China
2
Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, South China Agricultural University, Guangzhou 510642, China
3
National Reference Laboratory of Veterinary Drug Residues, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China
4
Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China
5
Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou 510642, China
*
Author to whom correspondence should be addressed.
Submission received: 10 April 2022 / Revised: 17 May 2022 / Accepted: 18 May 2022 / Published: 20 May 2022
(This article belongs to the Section Animal Genetics and Genomics)

Abstract

:

Simple Summary

This is a study related to NDM-5-producing E. coli in companion animals in China. Notably, an E. coli isolate possessing both blaNDM-5-bearing plasmid and mcr-1-bearing plasmid was identified in a dog from the same veterinary clinic, where we previously found the mobile IncX3–X4 hybrid plasmid encoding both blaNDM-5 and mcr-1 in a cat. This observation highlights the diversity of blaNDM-5- and mcr-1-harboring plasmids and the transferability of such resistant pathogens from companion animals to humans. Given that colistin is the last-resort antibiotic for treating human infections caused by carbapenem-resistant Enterobacteriaceae, the co-transfer of resistance to both antibiotics may seriously compromise the effectiveness of clinical therapy.

Abstract

Carbapenem and colistin are important antibiotics for the treatment of infections caused by multidrug-resistant Gram-negative pathogens. Here, we isolated the blaNDM-5-harboring Escherichia coli in companion animals in healthy or diseased companion animals from veterinary clinics in six cities in China from July to November 2016. A total of 129 rectal swabs of healthy or diseased dogs and cats were collected from veterinary clinics in six different cities in China, and the isolates were subjected to carbapenem and colistin susceptibility testing. Resistance genes were confirmed using PCR. Conjugation experiments were conducted to determine the transferability of antibiotic resistance genes (ARGs) in the strains. The isolated rate of blaNDM-5-harboring E. coli strains was 3.88% (five strains). These five strains were multidrug resistant to at least three antibiotics and corresponded to four sequence types including ST101. The blaNDM-5 gene was located on 46 kb IncX3 plasmids in these five strains, and the genetic contexts were shared and were nearly identical to the K. pneumoniae plasmid pNDM5-IncX3 from China. In addition, one strain (CQ6-1) co-harbored blaNDM-5-encoding-IncX3 plasmid along with a mcr-1-encoding-IncX4 plasmid, and their corresponding genetic environments were identical to the blaNDM-5-IncX3 and mcr-1-IncX4 hybrid plasmid reported previously from the same area and from the same clinic. The results indicated that the similar genetic contexts were shared between these isolates from companion animals, and the IncX3-type plasmids played a key role in the spread of blaNDM-5 among these bacteria.

1. Introduction

Antimicrobial resistance (AMR) within bacteria is a growing public health threat of concern because of the overuse of antibiotics. Notably, carbapenem resistance has spread globally, and carbapenem-resistant Enterobacteriaceae (CRE) are a current global health crisis. Carbapenems are broad-spectrum β-lactam antibiotics and are considered as a last resort for multidrug-resistant (MDR) bacterial infections. In 2013, the United States Centers for Disease Control and Prevention (CDC) proclaimed that CRE infections are one of the top three most urgent threats to public health due to antimicrobial resistance. In particular, the New Delhi metallo-β-lactamases (NDM), capable of hydrolyzing all penicillins, cephalosporins and carbapenems, is now present in more than 70 countries and has been identified on the bacterial chromosome as well as plasmids [1,2,3,4]. The NDM-5 variant differs from the prototype NDM-1 by the possession of two amino acid substitutions (Val88Leu and Met154Leu) that directly confer an increased level of resistance to carbapenems and to the broad-spectrum cephalosporins [5]. NDM-5 was first identified in the United Kingdom from a patient with a recent history of hospitalization in India in 2011 [5]. Subsequently, NDM-5 isolates have been reported in China, India, Japan, Australia and Algeria [6,7,8,9,10] and are commonly carried by Escherichia coli strains, and the majority of the latter have been recovered from human patients.
Colistin is a representative member of the family of cationic polypeptide antibiotics and is generally considered the last line of antibiotic against MDR Gram-negative pathogens. In 2015, the mcr-1-bearing plasmid, which confers resistance to colistin, was first reported [11], and this rapidly developed into another severe challenge for human health. In our previous study, we identified a hybrid IncX3-X4 plasmid (pCQ02-121) that co-harbored blaNDM-5 and mcr-1 in E. coli strain CQ02-121 isolated from a cat in Chongqing, China [12]. This hybrid plasmid was highly stable in both the original clinical isolate and corresponding transconjugants even in the absence of antibiotic selective pressure. This indicates that the strains of this type placed under selective pressures imposed by clinical treatments would most likely further increase the dissemination of the plasmid. Considering the close bond between companion animals and humans, it is likely that such a plasmid could be transferred to humans. Therefore, enhanced surveillance efforts are warranted to monitor the spread of these resistance elements.
In the current study, we investigated the prevalence of NDM-5-producing E. coli in companion animals in China and in an attempt to understand the dissemination of the IncX3-blaNDM-5-IncX4-mcr-1 hybrid plasmid that was characterized in our previous study.

2. Materials and Methods

2.1. Bacterial Isolation and Species Identification

From July to November 2015, a total of 129 rectal swabs of healthy or diseased dogs and cats were collected from veterinary clinics in six different cities including Harbin, Yangzhou, Chongqing, Wuhan, Chengdu and Guangzhou, in China (Figure 1). The information about the dogs and cats, including their age, gender, species, health status, reasons to go to the veterinarian was investigated (Table S3). All of the swabs were directly streaked onto MacConkey agar plates containing 1 mg/L meropenem and were incubated overnight at 37 °C; then, the agars with isolates were transferred to our lab within 24 h at low temperature. Colonies of different morphologies were picked and re-streaked for further identification. Bacterial species were identified by MALDI-TOF-MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry, Shimadzu-Biotech Corp., Kyoto, Japan).

2.2. AST and Detection of Carbapenemase-Encoding Genes

Antimicrobial susceptibility testing (AST) includes cefotaxime, ceftazidime, cefoxitin, meropenem, ertapenem, imipenem, aztreonam, amikacin, gentamicin, tobramycin, ciprofloxacin, tetracycline, tigecycline, fosfomycin, sulfamethoxazole–trimethoprim, colistin. The minimal inhibitory concentration (MIC) of these antimicrobial agents was determined by both agar dilution and micro-broth dilution based on the guideline of the Clinical and Laboratory Standards Institute (CLSI, 2015: M100-S28). E. coli American Type Culture Collection (ATCC) 25922 served as the quality control strain. Bacterial colonies were screened for carbapenemase production using the Carba NP test [13], and positive isolates were further screened for the presence of blaKPC, blaIMP, blaVIM, blaOXA-48 and blaNDM (Table S2) by polymerase chain reaction (PCR) amplification and amplicon sequencing [14].

2.3. Molecular Typing, Plasmid Analysis and DNA Sequencing

Genetic relationships between the blaNDM-5-positive E. coli isolates were evaluated by pulsed-field gel electrophoresis (PFGE) following digestion of XbaI [15]. Comparisons of PFGE patterns were analyzed using BioNumerics software (Applied Maths, Sint-Martens-Latem, Belgium). Multi-locus sequence typing (MLST) was performed using the protocol specified by the E. coli MLST web site [16].
Conjugation and electroporation were used to access transferability of resistant determinants using E. coli strain EC600Sm as the recipient [17]. Transconjugants were selected on MacConkey agar plates supplemented with meropenem and streptomycin and confirmed by both AST (as described in 2.4. Molecular Typing) and PCR amplification. Plasmid analysis of the transconjugants was carried out by DNA linearization with S1 nuclease followed by PFGE [18]. Plasmid DNA from CQ6-1T was sequenced using the HiSeq 2000 (Illumina) technology. Gene annotation and prediction were performed using RAST (Rapid Annotation using Subsystem Technology) and BLAST (Basic Local Alignment Search Tool) [19]. The complete sequence of pCQ61-NDM was taken as the reference sequence for PCR mapping of the blaNDM-5 genetic environment.

3. Results

3.1. Bacterial Strains and Antimicrobial Susceptibility Testing (AST)

We investigated six cities located in northern, central and southern China. The isolation rate for meropenem-resistant isolates was 17.05% (22/129 swab samples), and the detection rate of blaNDM-5-carrying E. coli was 3.88% (five isolates), all from companion animals. The 5 blaNDM-5-positive E. coli strains were recovered from three different cities, Yangzhou (strain YZ-10), Chongqing (strains CQ6-1 and CQ6-3) and Guangzhou (strains GZ03 and GZ09), respectively (Figure 2). These five isolates harbored the blaNDM-5 allele that exhibited 100% nucleotide identity to the same gene from E. coli EC405 that was confirmed using CarbaNP tests and PCR amplification. AST indicated that all five isolates were resistant to cephalosporins, carbapenems and co-trimoxazole but were susceptible to amikacin and tigecycline (Figure 3, Table S1). Notably, strain CQ6-1 was also resistant to aztreonam, gentamicin and colistin, and the presence of mcr-1 was identified simultaneously. These strains tested negative for the presence of blaKPC, blaVIM, blaIMP and blaOXA.

3.2. Genetic Relatedness of Isolates

A multi-locus sequence typing (MLST) analysis indicated that these five blaNDM-5-harboring E. coli isolates comprised four kinds of sequence types: ST101 and ST3902 from Chongqing, ST1415 from Guangzhou and ST2115 from Yangzhou. PFGE also revealed that GZ03 and GZ09 were clonally related, and the others belonged to different clusters. Notably, CQ6-1 and CQ6-3 were isolated from the same dog but belonged to different STs (Figure 3).

3.3. Characteristics of the BlaNDM-5-Carrying Plasmids

Conjugation experiments coupled with PCR tests indicated that the blaNDM-5-carrying plasmids were able to be transferred to the strain EC600Sm except for CQ6-3, which was obtained via electroporation of the plasmid. In strain CQ6-1, the mcr-1 gene was mobilized and co-transferred by conjugation to EC600Sm. Transconjugants were resistant to the β-lactams meropenem, imipenem, ertapenem and cephalosporins but not to aztreonam. S1 nuclease-PFGE analysis of the transconjugants and the transformant revealed that all blaNDM-5 genes were located on plasmids of the same approximate size 46 kb (Figure S1). PCR-based replicon typing confirmed that all these blaNDM-5-encoding plasmids were type IncX3 (pNDM5-IncX3) and their genetic contexts were >99.99% identical to that of pNDM_IncX3, taken from Klebsiella pneumoniae in China (GenBank Acc. no. KU761328). The blaNDM-5 genes were adjacent to an upstream truncated ISAba125 that was interrupted by insertion of IS5, and the genes ble, trpF, dsbC and a remnant of ctuA1, truncated by the insertion of IS26, were located immediately adjacent downstream.
The transconjugant CQ6-1T contained not only pNDM5-IncX3 but also an mcr-1-encoding IncX4 plasmid (pCQ61-MCR) indicating the co-transfer of both blaNDM-5 and mcr-1 carrying plasmids. pCQ61-MCR was 33,310 bp in length and had 100% BLAST query coverage and 99.9% nucleotide identity to plasmid pMCR1-IncX4 (GenBank Acc. no. KU761327). Since strain CQ6-1 was isolated from the same area as the previously reported strain CQ02-121 that possessed an IncX3-IncX4 hybrid plasmid as well as mcr-1, as expected, blaNDM-5 and mcr-1 align between the CQ02-121 hybrid with the pCQ61-NDM and pCQ61-MCR plasmids in CQ6-1 (Figure 4).

4. Discussion

To the best of our knowledge, this is the first study of NDM-5-producing Enterobacteriaceae in companion animals in China. Since its first identification in the UK, blaNDM-5 has been detected in clinical isolates belonging to many STs from Asia, Africa, Europe, Australia and the United States [6,7,8,20,21,22,23,24,25,26]. In contrast, the prevalence of NDM isolates from companion animals has been sporadic [27,28,29,30]. The first four cases were from dogs in Algeria, Finland, South Korea and the United States, and the fifth was an ST156 isolate from a cat. In the current study, we found that in six cities, the prevalence of resistant bacteria was 17% with blaNDM-5-harboring E. coli at 3.86% overall from companion animals in China. This rate of blaNDM-5-positive isolates in companion animals was closer to human clinical data [31,32]. The presence of these isolates in companion animals has become a potential risk and that the transmission of carbapenem and colistin resistance has been shared between humans and companion animals.
MLST analysis revealed that five blaNDM-5-positive E. coli belonged to four STs among which an epidemic clone ST101 was in isolate CQ6-1 from Chongqing. E. coli ST101 differs from the ST131 isolates that have been previously associated with the clonal dissemination of extended spectrum β-lactamases. At the initial epidemic stage of blaNDM, ST101 was the most prevalent ST associated with blaNDM-1 in a collection of isolates from England and Pakistan, as well as Australia, Germany, Denmark and Bulgaria [3,33,34,35]. NDM-5-producing E. coli have also been typically described as ST101 members [36], although two novel variants NDM-8 [37] and NDM-13 [38] were both initially detected in E. coli ST101. All the evidence indicates that ST101 has become an important reservoir of blaNDM-1 and its variants.
It is noteworthy that we found two NDM-5-producing strains (CQ6-1 and CQ6-3) that were isolated from the same dog but possessed different STs and PFGE patterns and shared an identical genetic environment (Figure 3). The horizontal gene transfer of multiple blaNDM-5-carrying E. coli strains in the dog was most likely responsible for this phenomenon. In addition, isolate CQ6-1 was resistant to both carbapenems and colistin. In agreement with the resistance phenotype, this strain contained both blaNDM-5 and mcr-1, and the blaNDM-5-encoding plasmid was almost identical to the IncX3 plasmid pNDM5-IncX3 and mcr-1-encoding plasmid pCQ61-MCR, which showed nearly the same nucleotide sequence as IncX4 plasmid pMCR1-IncX4 from K. pneumoniae [39]. In our previous study, the isolate CQ02-121 harbored blaNDM-5 and mcr-1 on a transferable IncX3-X4 hybrid plasmid [12]. Strain CQ6-1 was isolated from the same veterinary clinic in Chongqing, China as CQ02-121 but contained blaNDM-5 and mcr-1 on separate IncX3 and IncX4 plasmids, demonstrating that blaNDM-5 and mcr-1 plasmids may evolve by hybridization or by splitting to transfer the resistance genes under antibiotic selective pressure. Based on existing reports and the present study, the most likely scenario for this is that the initial strains harboring blaNDM-5 or mcr-1 existed in human and animals and under selective antibiotic pressure moved between human and animal hosts and further formed strains that co-harbored blaNDM-5 and mcr-1. This type of transmission contributes to ARG dissemination and could risk human health. We therefore performed a Web of Science database search for the presence of NDM and MCR co-producing strains. The vast majority have been detected in China, suggesting that dissemination of such strains in China has been extremely rapid and may eventually facilitate transmission to other parts of the world through traffic and trade.
IncX3 plasmids are narrow-host-range plasmids in the Enterobacteriaceae and are a common vehicle for blaNDM transmission. Plasmids that contain blaNDM alleles and especially the blaNDM-4-like variants (blaNDM-4, blaNDM-5, blaNDM-7 and blaNDM-8) were found to have nearly identical backbones regardless of the original strain background [40,41]. Since the discovery of the blaNDM-4-like variants, blaNDM-4 and blaNDM-5 have been identified in Enterobacteriaceae from humans, milk, sewage, dogs, fish and ducks across five continents. The genetic contexts for the placement of blaNDM within the plasmids from these strains were nearly identical, suggesting that the IncX3 plasmid carrying blaNDM-1/4/5/7 had a common plasmid ancestor.

5. Conclusions

In conclusion, this study characterized NDM-5-producing E. coli from companion animals in China. The blaNDM-5 gene was located on a 46 kb transmissible IncX3 plasmid in all five isolates, and the genetic context of the IncX3 plasmids was nearly identical to that of the K. pneumoniae plasmid pNDM5-IncX3 previously reported from China [39]. Importantly, blaNDM-5 and mcr-1 were able to co-transfer to the recipient, suggesting that plasmid transmissibility contributes to the dissemination of blaNDM-5 in companion animals. Companion animals have close relationships with humans and may play an essential role in the transmission of carbapenemase-producing isolates, as well as act as a reservoir of important resistance genes. Further monitoring and study might be necessary to survey the dissemination of carbapenemase-producing pathogens and to investigate the prevalence of carbapenem and colistin resistance.

Supplementary Materials

The following supporting information can be downloaded at: https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/ani12101310/s1, Figure S1: Localization of blaNDM-5 carrying plasmids by S1 nuclease PFGE and Southern hybridization. (a) S1-PFGE gel of the transconjugants/transformant. (b) Southern hybridization conducted with a probe specific for blaNDM. Line 1, GZ-03-T; Line 2, GZ-09-T; Line 3, CQ-61-T; Line 4, CQ-63-T; Line 5, CQ02-121T; Line 6, YZ-10-T. Table S1: MICs of sixteen antimicrobials agents against NDM-5-positive isolates and transconjugants. Table S2: Primer sequences for carbapenem resistance genes. Table S3: Samples information.

Author Contributions

Conceptualization, Y.Y. and J.S.; Data curation, R.Y., X.K. and X.Y.; Formal analysis, R.Y. and X.K.; Funding acquisition, Y.L. and X.L.; Methodology, R.Y. and X.K.; Project administration, J.S. and X.L.; Supervision, Y.Y. and Y.L.; Validation, R.Y.; Writing—original draft, X.K. and Y.Y.; Writing—review and editing, Y.Y. and J.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (31730097 and 31772793), the National Science and Technology Major Project (2018ZX10714002) and the Innovation Team Project of Guangdong University (2019KXTD001). Runshi Yang was funded by GDAS’ Project of Science and Technology Development (2020GDASYL-20200103031).

Institutional Review Board Statement

The sampling of animals was conducted in accordance with the principles of the South China Agriculture University Animal Ethics Committee (Number: 2015G001).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data will be available with the corresponding author upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pfeifer, Y.; Witte, W.; Holfelder, M.; Busch, J.; Nordmann, P.; Poirel, L. NDM-1-Producing Escherichia coli in Germany. Antimicrob. Agents Chemother. 2011, 55, 1318–1319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Poirel, L.; Fortineau, N.; Nordmann, P. International Transfer of NDM-1-Producing Klebsiella Pneumoniae from Iraq to France. Antimicrob. Agents Chemother. 2011, 55, 1821–1822. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Poirel, L.; Lagrutta, E.; Taylor, P.; Pham, J.; Nordmann, P. Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia. Antimicrob. Agents Chemother. 2010, 54, 4914–4916. [Google Scholar] [CrossRef] [Green Version]
  4. Zong, Z.; Zhang, X. BlaNDM-1-Carrying Acinetobacter Johnsonii Detected in Hospital Sewage. J. Antimicrob. Chemother. 2013, 68, 1007–1010. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Hornsey, M.; Phee, L.; Wareham, D.W. A Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom. Antimicrob. Agents Chemother. 2011, 55, 5952–5954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Yang, P.; Xie, B.Y.; Feng, P.; Zonga, Z. BlaNDM-5 Carried by an IncX3 Plasmid in Escherichia coli Sequence Type 167. Antimicrob. Agents Chemother. 2014, 58, 7548–7552. [Google Scholar] [CrossRef] [Green Version]
  7. Ghatak, S.; Singha, A.; Sen, A.; Guha, C.; Ahuja, A.; Bhattacharjee, U.; Das, S.; Pradhan, N.R.; Puro, K.; Jana, C.; et al. Detection of New Delhi Metallo-Beta-Lactamase and Extended-Spectrum Beta-Lactamase Genes in Escherichia coli Isolated from Mastitic Milk Samples. Transbound. Emerg. Dis. 2013, 60, 385–389. [Google Scholar] [CrossRef]
  8. Nakano, R.; Nakano, A.; Hikosaka, K.; Kawakami, S.; Matsunaga, N.; Asahara, M.; Ishigaki, S.; Furukawa, T.; Suzuki, M.; Shibayama, K.; et al. First Report of Metallo-β-Lactamase NDM-5-Producing Escherichia coli in Japan. Antimicrob. Agents Chemother. 2014, 58, 7611–7612. [Google Scholar] [CrossRef] [Green Version]
  9. Wailan, A.M.; Paterson, D.L.; Caffery, M.; Sowden, D.; Sidjabat, H.E. Draft Genome Sequence of NDM-5-Producing Escherichia coli Sequence Type 648 and Genetic Context of BlaNDM-5 in Australia. Genome Announc. 2016, 3, e00194-15. [Google Scholar] [CrossRef] [Green Version]
  10. Sassi, A.; Loucif, L.; Gupta, S.K.; Dekhil, M.; Chettibi, H.; Rolain, J.M. NDM-5 Carbapenemase-Encoding Gene in Multidrug-Resistant Clinical Isolates of Escherichia coli from Algeria. Antimicrob. Agents Chemother. 2014, 58, 5606–5608. [Google Scholar] [CrossRef] [Green Version]
  11. Liu, Y.Y.; Wang, Y.; Walsh, T.R.; Yi, L.X.; Zhang, R.; Spencer, J.; Doi, Y.; Tian, G.; Dong, B.; Huang, X.; et al. Emergence of Plasmid-Mediated Colistin Resistance Mechanism MCR-1 in Animals and Human Beings in China: A Microbiological and Molecular Biological Study. Lancet Infect. Dis. 2016, 16, 161–168. [Google Scholar] [CrossRef]
  12. Sun, J.; Yang, R.S.; Zhang, Q.; Feng, Y.; Fang, L.X.; Xia, J.; Li, L.; Lv, X.Y.; Duan, J.H.; Liao, X.P.; et al. Co-Transfer of BlaNDM-5 and Mcr-1 by an IncX3-X4 Hybrid Plasmid in Escherichia coli. Nat. Microbiol. 2016, 1, 3–6. [Google Scholar] [CrossRef] [PubMed]
  13. Nordmann, P.; Poirel, L.; Dortet, L. Rapid Detection of Carbapenemase-Producing Enterobacteriaceae. Emerg. Infect. Dis. 2012, 18, 1503–1507. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Poirel, L.; Walsh, T.R.; Cuvillier, V.; Nordmann, P. Multiplex PCR for Detection of Acquired Carbapenemase Genes. Diagn. Microbiol. Infect. Dis. 2011, 70, 119–123. [Google Scholar] [CrossRef]
  15. Tenover, F.C.; Arbeit, R.D.; Goering, R.V.; Mickelsen, P.A.; Murray, B.E.; Persing, D.H.; Swaminathan, B. Interpreting Chromosomal DNA Restriction Patterns Produced by Pulsed-Field Gel Electrophoresis: Criteria for Bacterial Strain Typing. J. Clin. Microbiol. 1995, 33, 2233–2239. [Google Scholar] [CrossRef] [Green Version]
  16. Wirth, T.; Falush, D.; Lan, R.; Colles, F.; Mensa, P.; Wieler, L.H.; Karch, H.; Reeves, P.R.; Maiden, M.C.J.; Ochman, H.; et al. Sex and Virulence in Escherichia coli: An Evolutionary Perspective. Mol. Microbiol. 2006, 60, 1136–1151. [Google Scholar] [CrossRef] [Green Version]
  17. Lorenzo-Díaz, F.; Espinosa, M. Lagging-Strand DNA Replication Origins Are Required for Conjugal Transfer of the Promiscuous Plasmid PMV158. J. Bacteriol. 2009, 191, 720–727. [Google Scholar] [CrossRef] [Green Version]
  18. Barton, B.M.; Harding, G.P.; Zuccarelli, A.J. A General Method for Detecting and Sizing Large Plasmids. Anal. Biochem. 1995, 226, 235–240. [Google Scholar] [CrossRef]
  19. Aziz, R.K.; Bartels, D.; Best, A.; DeJongh, M.; Disz, T.; Edwards, R.A.; Formsma, K.; Gerdes, S.; Glass, E.M.; Kubal, M.; et al. The RAST Server: Rapid Annotations Using Subsystems Technology. BMC Genom. 2008, 9, 75. [Google Scholar] [CrossRef] [Green Version]
  20. Balm, M.N.D.; La, M.V.; Krishnan, P.; Jureen, R.; Lin, R.T.P.; Teo, J.W.P. Emergence of Klebsiella Pneumoniae Co-Producing NDM-Type and OXA-181 Carbapenemases. Clin. Microbiol. Infect. 2013, 19, E421–E423. [Google Scholar] [CrossRef] [Green Version]
  21. Cho, S.Y.; Huh, H.J.; Baek, J.Y.; Chung, N.Y.; Ryu, J.G.; Ki, C.S.; Chung, D.R.; Lee, N.Y.; Song, J.H. Klebsiella Pneumoniae Co-Producing NDM-5 and OXA-181 Carbapenemases, South Korea. Emerg. Infect. Dis. 2015, 21, 1088–1089. [Google Scholar] [CrossRef] [PubMed]
  22. Khalifa, H.O.; Soliman, A.M.; Ahmed, A.M.; Shimamoto, T.; Shimamoto, T. NDM-4- and NDM-5-Producing Klebsiella Pneumoniae Coinfection in a 6-Month-Old Infant. Antimicrob. Agents Chemother. 2016, 60, 4416–4417. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Bathoorn, E.; Rossen, J.W.; Lokate, M.; Friedrich, A.W.; Hammerum, A.M. Isolation of an NDM-5-Producing ST16 Klebsiella Pneumoniae from a Dutch Patient without Travel History Abroad, August 2015. Eurosurveillance 2015, 20, 30040. [Google Scholar] [CrossRef] [PubMed]
  24. Hammerum, A.M.; Littauer, P.; Hansen, F. Detection of Klebsiella Pneumoniae Co-Producing NDM-7 and OXA-181, Escherichia coli Producing NDM-5 and Acinetobacter Baumannii Producing OXA-23 in a Single Patient. Int. J. Antimicrob. Agents 2015, 46, 597–598. [Google Scholar] [CrossRef] [PubMed]
  25. Wailan, A.M.; Paterson, D.L.; Kennedy, K.; Ingram, P.R.; Bursle, E.; Sidjabat, H.E. Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their BlaNDM Genetic Contexts. Antimicrob. Agents Chemother. 2016, 60, 136–141. [Google Scholar] [CrossRef] [Green Version]
  26. De Man, T.J.B.; Perry, K.A.; Avillan, J.J.; Rasheed, J.K.; Limbago, B.M. Draft Genome Sequence of a New Delhi Metallo-β-Lactamase-5 (NDM-5)-Producing Multidrugresistant Escherichia coli Isolate. Genome Announc. 2016, 3, e00017-15. [Google Scholar] [CrossRef] [Green Version]
  27. Grönthal, T.; Österblad, M.; Eklund, M.; Jalava, J.; Nykäsenoja, S.; Pekkanen, K.; Rantala, M. Sharing More than Friendship—Transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between Dogs and Humans in a Family, Finland, 2015. Eurosurveillance 2018, 23, 1700497. [Google Scholar] [CrossRef]
  28. Cole, S.D.; Peak, L.; Tyson, G.H.; Reimschuessel, R.; Ceric, O.; Rankin, S.C. New Delhi Metallo-β-Lactamase-5-Producing Escherichia coli in Companion Animals, United States. Emerg. Infect. Dis. 2020, 26, 381–383. [Google Scholar] [CrossRef] [Green Version]
  29. Hong, J.S.; Song, W.; Park, H.M.; Oh, J.Y.; Chae, J.C.; Han, J.I.; Jeong, S.H. First Detection of New Delhi Metallo-β-Lactamase-5-Producing Escherichia coli from Companion Animals in Korea. Microb. Drug Resist. 2019, 25, 344–349. [Google Scholar] [CrossRef] [PubMed]
  30. Yousfi, M.; Touati, A.; Mairi, A.; Brasme, L.; Gharout-Sait, A.; Guillard, T.; De Champs, C. Emergence of Carbapenemase-Producing Escherichia coli Isolated from Companion Animals in Algeria. Microb. Drug Resist. 2016, 22, 342–346. [Google Scholar] [CrossRef]
  31. Liu, B.T.; Song, F.J.; Zou, M.; Zhang, Q.D.; Shan, H. High Incidence of Escherichia coli Strains Coharboring Mcr-1 and BlaNDM from Chickens. Antimicrob. Agents Chemother. 2017, 61, e02347-16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Wang, Y.; Zhang, R.; Li, J.; Wu, Z.; Yin, W.; Schwarz, S.; Tyrrell, J.M.; Zheng, Y.; Wang, S.; Shen, Z.; et al. Comprehensive Resistome Analysis Reveals the Prevalence of NDM and MCR-1 in Chinese Poultry Production. Nat. Microbiol. 2017, 2, 16260. [Google Scholar] [CrossRef] [PubMed]
  33. Mushtaq, S.; Irfan, S.; Sarma, J.B.; Doumith, M.; Pike, R.; Pitout, J.; Livermore, D.M.; Woodford, N. Phylogenetic Diversity of Escherichia coli Strains Producing NDM-Type Carbapenemases. J. Antimicrob. Chemother. 2011, 66, 2002–2005. [Google Scholar] [CrossRef] [PubMed]
  34. Nielsen, J.B.; Hansen, F.; Littauer, P.; Schønning, K.; Hammerum, A.M. An NDM-1-Producing Escherichia coli Obtained in Denmark Has a Genetic Profile Similar to an NDM-1-Producing E. Coli Isolate from the UK. J. Antimicrob. Chemother. 2012, 67, 2049–2051. [Google Scholar] [CrossRef] [Green Version]
  35. Poirel, L.; Savov, E.; Nazli, A.; Trifonova, A.; Todorova, I.; Gergova, I.; Nordmann, P. Outbreak Caused by NDM-1- and RmtB-Producing Escherichia coli in Bulgaria. Antimicrob. Agents Chemother. 2014, 58, 2472–2474. [Google Scholar] [CrossRef] [Green Version]
  36. Park, M.; Park, S.D.; Lee, M.H.; Kim, S.H.; Lim, K.; Lee, G.; Woo, H.J.; Kim, H.W.; Yang, J.Y.; Eom, Y.B.; et al. The First Report of NDM-5-Producing Uropathogenic Escherichia coli Isolates in South Korea. Diagn. Microbiol. Infect. Dis. 2016, 85, 198–199. [Google Scholar] [CrossRef]
  37. Tada, T.; Miyoshi-Akiyama, T.; Dahal, R.K.; Sah, M.K.; Ohara, H.; Kirikae, T.; Pokhrel, B.M. NDM-8 Metallo-Βlactamase in a Multidrug-Resistant Escherichia coli Strain Isolated in Nepal. Antimicrob. Agents Chemother. 2013, 57, 2394–2396. [Google Scholar] [CrossRef] [Green Version]
  38. Shrestha, B.; Tada, T.; Miyoshi-Akiyama, T.; Shimada, K.; Ohara, H.; Kirikae, T.; Pokhrel, B.M. Identification of a Novel NDM Variant, NDM-13, from a Multidrug-Resistant Escherichia coli Clinical Isolate in Nepal. Antimicrob. Agents Chemother. 2015, 59, 5847–5850. [Google Scholar] [CrossRef] [Green Version]
  39. Li, A.; Yang, Y.; Miao, M.; Chavda, K.D.; Mediavilla, J.R.; Xie, X.; Feng, P.; Tang, Y.W.; Kreiswirth, B.N.; Chen, L.; et al. Complete Sequences of Mcr-1-Harboring Plasmids from Extended-Spectrum-β-Lactamase- and Carbapenemase-Producing Enterobacteriaceae. Antimicrob. Agents Chemother. 2016, 60, 4351–4354. [Google Scholar] [CrossRef] [Green Version]
  40. Chen, L.; Peirano, G.; Lynch, T.; Chavda, K.D.; Gregson, D.B.; Church, D.L.; Conly, J.; Kreiswirth, B.N.; Pitout, J.D. Molecular Characterization by Using Next-Generation Sequencing of Plasmids Containing BlaNDM-7in Enterobacteriaceae from Calgary, Canada. Antimicrob. Agents Chemother. 2016, 60, 1258–1263. [Google Scholar] [CrossRef] [Green Version]
  41. Pál, T.; Ghazawi, A.; Darwish, D.; Villa, L.; Carattoli, A.; Hashmey, R.; Aldeesi, Z.; Jamal, W.; Rotimi, V.; Al-Jardani, A.; et al. Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula. Microb. Drug Resist. 2017, 23, 871–878. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Map of sampling sites. The black dots represent the cities that the veterinary clinics were located in. The number of samples are marked after the name of cities.
Figure 1. Map of sampling sites. The black dots represent the cities that the veterinary clinics were located in. The number of samples are marked after the name of cities.
Animals 12 01310 g001
Figure 2. The detection rate of blaNDM-5-carrying E. coli. The black dots represent the cities that the veterinary clinics are located in. The isolation rate of carbapenems non-susceptible bacteria and detection rate of blaNDM-positive E. coli isolates are tagged as well.
Figure 2. The detection rate of blaNDM-5-carrying E. coli. The black dots represent the cities that the veterinary clinics are located in. The isolation rate of carbapenems non-susceptible bacteria and detection rate of blaNDM-positive E. coli isolates are tagged as well.
Animals 12 01310 g002
Figure 3. Clonal relationship, plasmid characteristics and antibiotic resistance phenotype of the five blaNDM-5-positive E. coli isolates. Dendrograms based on XbaI-restriction patterns of E. coli isolates producing NDM-5. The number on the left represents the similarity between corresponding strains. E. coli isolates showing similarities of <85% were considered to be unrelated. CTX, cefotaxime; CAZ, ceftazidime; FOX, cefoxitin; MEM, meropenem; ERT, ertapenem; IMP, imipenem; ATM, aztreonam; GEN, gentamicin; CIP, ciprofloxacin; TET, tetracycline; FOS, fosfomycin; CS, colistin; SXT, sulfamethoxazole–trimethoprim.
Figure 3. Clonal relationship, plasmid characteristics and antibiotic resistance phenotype of the five blaNDM-5-positive E. coli isolates. Dendrograms based on XbaI-restriction patterns of E. coli isolates producing NDM-5. The number on the left represents the similarity between corresponding strains. E. coli isolates showing similarities of <85% were considered to be unrelated. CTX, cefotaxime; CAZ, ceftazidime; FOX, cefoxitin; MEM, meropenem; ERT, ertapenem; IMP, imipenem; ATM, aztreonam; GEN, gentamicin; CIP, ciprofloxacin; TET, tetracycline; FOS, fosfomycin; CS, colistin; SXT, sulfamethoxazole–trimethoprim.
Animals 12 01310 g003
Figure 4. Linear sequence comparisons of pCQ61-NDM and pCQ61-MCR with other plasmids, including pMCR1_IncX4 (GenBank Acc. no. KU761327), pNDM5_IncX3 (GenBank Acc. no. KU761328) and from our previous study pCQ02-121 (GenBank Acc. no. KU647721). Boxed arrows represent the position and transcriptional direction of ORFs (open reading frames). Regions of >99% identity are marked by grey shading. Dark blue represents replication-associated genes, and light blue represents genes associated with the pil, tra and vir loci. ARGs are colored red; insertion sequences are colored green.
Figure 4. Linear sequence comparisons of pCQ61-NDM and pCQ61-MCR with other plasmids, including pMCR1_IncX4 (GenBank Acc. no. KU761327), pNDM5_IncX3 (GenBank Acc. no. KU761328) and from our previous study pCQ02-121 (GenBank Acc. no. KU647721). Boxed arrows represent the position and transcriptional direction of ORFs (open reading frames). Regions of >99% identity are marked by grey shading. Dark blue represents replication-associated genes, and light blue represents genes associated with the pil, tra and vir loci. ARGs are colored red; insertion sequences are colored green.
Animals 12 01310 g004
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kuang, X.; Yang, R.; Ye, X.; Sun, J.; Liao, X.; Liu, Y.; Yu, Y. NDM-5-Producing Escherichia coli Co-Harboring mcr-1 Gene in Companion Animals in China. Animals 2022, 12, 1310. https://0-doi-org.brum.beds.ac.uk/10.3390/ani12101310

AMA Style

Kuang X, Yang R, Ye X, Sun J, Liao X, Liu Y, Yu Y. NDM-5-Producing Escherichia coli Co-Harboring mcr-1 Gene in Companion Animals in China. Animals. 2022; 12(10):1310. https://0-doi-org.brum.beds.ac.uk/10.3390/ani12101310

Chicago/Turabian Style

Kuang, Xu, Runshi Yang, Xinqing Ye, Jian Sun, Xiaoping Liao, Yahong Liu, and Yang Yu. 2022. "NDM-5-Producing Escherichia coli Co-Harboring mcr-1 Gene in Companion Animals in China" Animals 12, no. 10: 1310. https://0-doi-org.brum.beds.ac.uk/10.3390/ani12101310

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop